- 专利标题： Tetrazole derivatives as TRPA1 inhibitors
-
申请号： US17356782申请日： 2021-06-24
-
公开(公告)号： US11891403B2公开(公告)日： 2024-02-06
- 发明人: Martin Thomas Fleck , Florian Paul Christian Binder , Jens Willwacher
- 申请人： Boehringer Ingelheim International GmbH
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim am Rhein
- 代理商 Philip I. Datlow
- 优先权： EP 182987 2020.06.29
- 主分类号： C07D498/04
- IPC分类号： C07D498/04 ; C07D471/04 ; C07D513/04
摘要：
The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
公开/授权文献
- US20210403482A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS 公开/授权日：2021-12-30
信息查询
